As part of the Protecting Patient Access to Emergency Medications Act of 2017, which was passed 3 years ago, the DEA was required to establish regulations associated with the use of controlled substances by EMS agencies. The DEA has now published in the Federal Register proposed rules to implement the law. Comments on the proposed rules can be submitted electronically or by mail on or before December 4, 2020. Individuals, agencies and organizations may submit comments.
Sign up to receive the latest news from the Office of EMS, including webinars, newsletters and industry updates.
1200 New Jersey Avenue, SE
Washington, DC 20590